These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20851461)

  • 1. Preventing HIV infection: turning the tide for young women.
    McCoy SI; Watts CH; Padian NS
    Lancet; 2010 Oct; 376(9749):1281-2. PubMed ID: 20851461
    [No Abstract]   [Full Text] [Related]  

  • 2. The introduction of new antiretroviral-based HIV prevention methods into health systems: an update.
    Daly F
    Reprod Health Matters; 2012 Jun; 20(39):215. PubMed ID: 22789099
    [No Abstract]   [Full Text] [Related]  

  • 3. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.
    McCormack S; Ramjee G; Kamali A; Rees H; Crook AM; Gafos M; Jentsch U; Pool R; Chisembele M; Kapiga S; Mutemwa R; Vallely A; Palanee T; Sookrajh Y; Lacey CJ; Darbyshire J; Grosskurth H; Profy A; Nunn A; Hayes R; Weber J
    Lancet; 2010 Oct; 376(9749):1329-37. PubMed ID: 20851460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Still a long wait for approved HIV-protective gel.
    Bateman C
    S Afr Med J; 2010 Sep; 100(9):560, 562. PubMed ID: 20822637
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV/AIDS. At last, vaginal gel scores victory against HIV.
    Cohen J
    Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914
    [No Abstract]   [Full Text] [Related]  

  • 6. A second chance for microbicides.
    Baleta A
    Lancet; 2007 Jul; 370(9581):17-8. PubMed ID: 17632853
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbicide research already benefiting thousands--experts.
    Bateman C
    S Afr Med J; 2009 Sep; 99(9):628-30. PubMed ID: 20073283
    [No Abstract]   [Full Text] [Related]  

  • 8. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK; Vanham G
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.
    Abdool Karim SS
    Future Microbiol; 2010 Apr; 5(4):527-9. PubMed ID: 20353292
    [No Abstract]   [Full Text] [Related]  

  • 10. Starting to gel.
    Pilcher H
    Nature; 2004 Jul; 430(6996):138-40. PubMed ID: 15241385
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda.
    Abaasa A; Crook A; Gafos M; Anywaine Z; Levin J; Wandiembe S; Nanoo A; Nunn A; McCormack S; Hayes R; Kamali A
    Trials; 2013 Feb; 14():33. PubMed ID: 23374729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir gel--the new HIV prevention 'banker'?
    Bateman C
    S Afr Med J; 2007 Jul; 97(7):496, 498. PubMed ID: 17805450
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV prevention in women: next steps.
    Vermund SH; Van Damme L
    Science; 2011 Jan; 331(6015):284. PubMed ID: 21252332
    [No Abstract]   [Full Text] [Related]  

  • 14. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
    Keller MJ; Guzman E; Hazrati E; Kasowitz A; Cheshenko N; Wallenstein S; Cole AL; Cole AM; Profy AT; Wira CR; Hogarty K; Herold BC
    AIDS; 2007 Feb; 21(4):467-76. PubMed ID: 17301565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti HIV gel shows no promise in clinical trial.
    AORN J; 2009 Apr; 89(4):748. PubMed ID: 19434949
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial.
    Sokal DC; Karim QA; Sibeko S; Yende-Zuma N; Mansoor LE; Baxter C; Grobler A; Frolich J; Kharsany AB; Miya N; Mlisana K; Maarshalk S; Karim SS
    Antivir Ther; 2013; 18(3):301-10. PubMed ID: 22914267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicides--women pray for success.
    Bateman C
    S Afr Med J; 2006 Jun; 96(6):493-4. PubMed ID: 16841128
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
    Cohen JA; Brache V; Foster J; Cochon L; Callahan M; Schwartz J
    Sex Transm Dis; 2013 Jun; 40(6):476-81. PubMed ID: 23677021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.
    Clark MR; Friend DR
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1458-66. PubMed ID: 22394281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.